ognizant Communication Corporation

Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

American Office (for submissions from American and European countries): Professor Alan C. Sartorelli, Publication Office, Oncology Research, 12 Peaceful Drive, New Fairfield, CT 06812, USA. Tel: 203-702-4436, Fax: 203-702-0631, E-mail: oracdd@charter.net

Asian Office (for submissions from Asian countries): Professor Takashi Tsuruo, Director, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Ariake 3-10-6, Koto-ku, Tokyo 135-8550, Japan. Tel: +81-3-3570-0480, Fax: +81-3-3570-0482, E-mail: ritsuko.mihara@jfcr.or.jp

Types of Contributions: The Journal publishes full-length papers and short communications, in English, describing the results of original experiments in basic and clinical cancer research. Commentaries, short research editorials of between 3,000 and 5,000 words in length (12–20 typewritten pages, double-spaced) are also published. These are editorial statements intended to stimulate thought on selected topics and should not be exhaustive reviews. They can be controversial and can focus on areas subject to much activity, or draw attention to relatively neglected fields in which there are both opportunities and the need for research. Authors may present personal views on the state of the subject on which they are reporting, and give their view as to where in the near or distant future the subject may be moving. Authors are encouraged to take issue with popular dogmas. Manuscripts are published in the shortest time possible commensurate with scientific quality.

Submission Requirements: Authors are requested to submit the original manuscript (and revised manuscript if needed) electronically via email to one of the offices listed above. Send the text portion of the manuscript, including tables and figure legends, as an email attachment in either PDF or Microsoft Word (IBM compatible) format. Send the figures as separate files in PDF format (or in Microsoft Word, or as tiff or jpeg). Note that large graphic files, especially color, may need to be compressed (zipped) to send via email. PDF format is preferred for figure files. If the quality of the materials is not suitable, authors will be requested to provide them by postal mail.

Include a cover letter, and insert “Oncology Research Submission” in the subject line of the email. The cover letter should contain the name, address, telephone, and fax number and electronic mail address of the author responsible for correspondence. Follow the General Manuscript Form guidelines below to prepare the manuscript, figures, and tables.

When the manuscript is accepted for publication, the author(s) will be required to provide two hard copies of the manuscript, two high-quality copies of all artwork, and a CD or disk (see Final Accepted Manuscript/Disk below).

Manuscripts are accepted for consideration with the understanding that they have not been published elsewhere except in abstract form and are not concurrently under review elsewhere. Material accepted for publication will not be released publicly prior to its appearance in the journal.

General Manuscript Form: Papers should be typed in English, double spaced throughout with at least 3-cm margins on paper approximately 22 × 28 cm (8 1/2 × 11 in.) in size. Please consult the most recent issue of the journal for style and format. Number all pages consecutively, beginning with the title page. Use metric units of measure; other units may be given in parentheses. Typically, only three levels of headings are recognized. The paper should be organized as follows.

Title Page: The title should be brief and specific. The title page should contain in the following order: title, name(s) and affiliation(s) of author(s) including city, state, postal code, and country, and a suggested short title for the running head of not more than 50 characters and spaces. Also indicate the author to whom correspondence should be addressed, with complete mailing address, telephone and fax numbers, and e-mail address.

Abstract/Key Words: An abstract of 300 words or less should begin on page 2. It should contain a concise summary of the results, conclusions, and other significant points. For the purpose of subject indexing, provide four to six key words immediately following the abstract.

Text: Arrange the text with main headings of Introduction, Materials and Methods, Results, Discussion, Acknowledgments (and source of funding), References, Tables, Figure legends (together, and separate from the figures), and Figures (each on a separate page). Use generic names of drugs. Give name, city and state, and country of the manufacturer of any chemicals, equipment, or software mentioned in the text. Define all nonstandard abbreviations the first time they appear in the text.

References/Reference List: Within the text references should be cited with sequential numbers in parentheses. The reference list should be numbered sequentially by order of appearance in the text. Follow the style samples given below. Journal citations in the reference list should contain the following: (a) surnames and initials of all authors (surnames precede initials); (b) title of article; (c) journal title abbreviated as listed in the List of Journals Indexed in Index Medicus; (d) volume, inclusive pages, and year.

Journal Article:
1. Moskowitz, N. K.; Borao, F. J.; Dardashti, O.; Cohen, H. D.; Germino, F. J. The amino terminus of cdk2 binds p21. Oncol. Res. 8:348–352; 1996.

Book
1. Sambrook, J.; Fritsch, E. F.; Maniatis, T. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.

Chapter in Edited Book:
1. Den Otter, E.; Dullens Hub, F. J.; Van Govern, H.; Pels, E. Antitumor effects of macrophages injected into animals: A review. In: MacBride, J. K.; Stuart, A., eds. The macrophage and cancer. Edinburgh: Econoprint; 1987:119–141.

Tables: Tables should be numbered and cited sequentially in the text. Prepare each table as a separate page at the end of the manuscript text, after the references. Avoid very wide or long tables that would not fit a printed page. Each table should have a title, and each column in the table should have a brief heading. Define all abbreviations in the table footnote at the bottom of the table.

Figures: Figures should be numbered and cited sequentially in the text. Prepare figures to provide high-quality hard copy output for final accepted submission (see Final Accepted Manuscript). Avoid light lettering and shading that will not reproduce well. Figure dimensions and scaling should be suitable for reduction (if necessary) to fit column or page size. Care must be taken that letters and other symbols do not become so small that they are illegible when the figure is reduced. Complex formulas should be prepared as illustrations. (Do not embed figures within the manuscript text. Prepare as separate files or at the end of the manuscript, after tables and figure legends.) The author is required to bear the costs for the publication of color figures (costs and color authorization form will be provided at proof stage).

Figure Legends: List all figure legends sequentially on one or more pages at the end of the manuscript text, after the references, and identify all symbols used in the figures. The figure legend should be as clear as possible and should fully describe the contents of the figure. (Do not include the figure legend as part of the figure.) If the figure is from a previously published article, indicate that permission has been obtained from the original publisher.

Permissions: If data from any other source is used in tables or figures it is the responsibility of the author(s) to obtain permission to reproduce such material. Provide proof that permission has been granted from the original publisher and indicate the source.

Final Accepted Manuscript/Disk: When the manuscript is accepted for publication, the author(s) must provide two hard copies of the manuscript, two high-quality copies of all artwork (glossy paper is preferred for photomicrographs and color figures), and a CD or disk. Ensure that the hard copy and electronic file match exactly. Photocopies or poor quality copies of figures are not acceptable. The final manuscript file (including tables and figure legends) must be submitted in IBM-compatible form, either as a Word document or as a plain text (ASCII) file. A PDF file at this stage is not acceptable. Identify all figures on the back with figure number, first author’s name, and indication of top of figure.

Page Proofs and Offprints: All material accepted for publication is subject to copyediting. Authors all editorial changes at this point. Only minor corrections are allowed at proof stage. Along with the page proofs, the corresponding author will receive a form for ordering reprints and full copies of the issue in which the article appears. All coauthor reprint requirements should be included on the Offprint Order Form.